Blood, 15 January 2004, Vol. 103, No. 2, pp. 701-709.
Prepublished online as a Blood First Edition Paper on August 14, 2003; DOI 10.1182/blood-2003-02-0478.
 Previous Article | Table of Contents | Next Article 
RED CELLS
Induction of human  globin gene expression by histone deacetylase inhibitors
Hua Cao,
George Stamatoyannopoulos, and
Manfred Jung
From the Division of Medical Genetics, University of Washington, Seattle; and Department of Pharmaceutical Chemistry, Westfälische-Wilhelms-Universität, Münster, Germany.
We investigated the induction of human  globin gene activity by 3 classes of histone deacetylase inhibitors: amide analogues of trichostatin A, hydroxamic acid analogues of trapoxin, and scriptaid and its analogues. The screening consisted of measuring the effects of these compounds on and  human gene promoter activity by using cultures of GM979 cells stably transfected with a construct containing a promoter linked to firefly luciferase and a promoter linked to renilla luciferase. Compounds belonging to all 3 classes induced gene promoter activity in the screening assay in low micromolar concentrations. Histone deacetylase (HDAC) inhibitors increased acetylation of histone H4 and induced the expression of endogenous murine embryonic genes. They also increased the levels of mRNA and the frequency of fetal hemoglobin-containing erythroblasts in erythroid burst-forming unit (BFUe) cultures from healthy adult individuals. Compounds that displayed very similar degrees of inhibition of the HDAC activity in an HDAC enzymatic assay differed strikingly on their effects on gene promoter activity, raising the possibility of selectivity of HDACs that interact with the globin gene chromatin.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
A. Mai, K. Jelicic, D. Rotili, A. Di Noia, E. Alfani, S. Valente, L. Altucci, A. Nebbioso, S. Massa, R. Galanello, et al.
Identification of Two New Synthetic Histone Deacetylase Inhibitors That Modulate Globin Gene Expression in Erythroid Cells from Healthy Donors and Patients with Thalassemia
Mol. Pharmacol.,
November 1, 2007;
72(5):
1111 - 1123.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Aerbajinai, J. Zhu, Z. Gao, K. Chin, and G. P. Rodgers
Thalidomide induces {gamma}-globin gene expression through increased reactive oxygen species mediated p38 MAPK signaling and histone H4 acetylation in adult erythropoiesis
Blood,
October 15, 2007;
110(8):
2864 - 2871.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Mankidy, D. V. Faller, R. Mabaera, C. H. Lowrey, M. S. Boosalis, G. L. White, S. A. Castaneda, and S. P. Perrine
Short-chain fatty acids induce {gamma}-globin gene expression by displacement of a HDAC3-NCoR repressor complex
Blood,
November 1, 2006;
108(9):
3179 - 3186.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. P. PERRINE, S. A. CASTANEDA, M. S. BOOSALIS, G. L. WHITE, B. M. JONES, and R. BOHACEK
Induction of Fetal Globin in {beta}-Thalassemia: Cellular Obstacles and Molecular Progress
Ann. N.Y. Acad. Sci.,
November 1, 2005;
1054(1):
257 - 265.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. P. Perrine
Fetal Globin Induction--Can It Cure {beta} Thalassemia?
Hematology,
January 1, 2005;
2005(1):
38 - 44.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Q. Zhao, H. Cumming, L. Cerruti, J. M. Cunningham, and S. M. Jane
Site-specific Acetylation of the Fetal Globin Activator NF-E4 Prevents Its Ubiquitination and Regulates Its Interaction with the Histone Deacetylase, HDAC1
J. Biol. Chem.,
October 1, 2004;
279(40):
41477 - 41486.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. R. Buchanan, M. R. DeBaun, C. T. Quinn, and M. H. Steinberg
Sickle Cell Disease
Hematology,
January 1, 2004;
2004(1):
35 - 47.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
